BCYC
Bicycle Therapeutics Ltd
3.40$
-5.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.8% | -8.1% | +93.3% | -5.7% | -4.0% | -7.6% | -5.9% | -8.2% | -6.1% | -9.1% | -7.0% | |
| – | -6.8% | -8.2% | +99.3% | -6.0% | -3.9% | -7.8% | -6.1% | -8.1% | -7.6% | -9.3% | -7.1% | |
| – | -8.0% | -13.2% | +110.4% | -7.3% | -1.3% | -9.8% | -9.0% | -10.1% | -3.1% | -10.9% | -8.8% | |
| – | -8.0% | -13.2% | +110.4% | -7.3% | -1.3% | -9.8% | -9.0% | -10.1% | -3.1% | -10.9% | -8.8% | |
| – | +39.1% | +62.5% | +19.5% | +24.2% | -38.5% | +30.1% | +31.0% | +10.7% | -47.1% | +15.0% | +15.9% | |
| – | – | – | +0.0% | -5,798,200,100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | -14.8% | -4.0% | -9.7% | -1.2% | -12.4% | +13.7% | -10.9% | -26.0% | -8.9% | -1.8% | |
| – | -0.3% | -28.8% | +40.6% | -19.0% | +19.2% | -14.3% | +34.4% | -10.5% | -17.8% | -14.2% | -2.6% | |
| – | +4.6% | +2.0% | +452.9% | -79.8% | -0.9% | +3.9% | -5.0% | -12.3% | -42.1% | -46.9% | – | |
| – | +53.7% | -45.9% | +5.6% | -23.3% | +176.4% | -29.7% | +64.4% | -30.7% | -23.6% | -38.3% | -5.2% | |
| – | +0.3% | +0.3% | -72.4% | – | – | – | – | – | – | – | – | |
| – | -10.8% | -4.0% | +145.4% | -4.9% | -4.6% | -6.6% | -9.6% | -7.5% | -1.4% | -9.1% | -7.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.2% | +0.3% | +22.2% | +32.7% | +0.1% | +0.2% | +0.1% | +0.1% | +0.1% | +0.5% | +0.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.